Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

JNJ

Johnson&Johnson

NYSE

Real-time Quotes | Nasdaq Last Sale

162.24

+1.85

+1.15%

After Hours: 162.00 -0.24 -0.15% 19:39 04/16 EDT

OPEN

161.34

PREV CLOSE

160.39

HIGH

162.51

LOW

160.56

VOLUME

9.05M

TURNOVER

52 WEEK HIGH

173.65

52 WEEK LOW

133.65

MARKET CAP

427.13B

P/E (TTM)

30.04

The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs

Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American Association of Cancer Research's annual meeting provided a platform for oncology-focuse...

Benzinga · 8h ago

Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe

The Moderna jab, which works in a similar way to the Pfizer vaccine, uses synthetic messenger RNA (mRNA) technology that can be quickly tweaked to address new mutations of a virus.

Yahoo Finance UK · 9h ago

Bloomberg New Economy Newsletter: Vaccine Inequality Makes Everyone Lose

When the U.S. Centers for Disease Control and Prevention paused use of the Johnson & Johnson vaccine this week “out of an abundance of caution,” many vaccination sites simply switched out J&J doses for those of Pfizer-BioNTech and Moderna. For America, it ...

Bloomberg · 10h ago

Australia Posts Third AstraZeneca-Linked Death: Virus Update

Bloomberg · 16h ago

Cramer's week ahead: The impact of inflation and the reopening as earnings season accelerates

Next week marks the beginning of the real earnings season, "Mad Money" host Jim Cramer said.

CNBC.com · 22h ago

DJ J&J, Morgan Stanley, Coinbase: Stocks That Defined the Week

Dow Jones · 22h ago

Concerns over inflationary pressure on earnings will test stocks in the week ahead

Earnings will be the major focus in the week ahead, as investors home in on whether rising costs are squeezing margins and signaling inflationary pressures.

CNBC.com · 1d ago

Wall St Week Ahead-Tech retakes market lead as investors eye yields, earnings

reuters.com · 1d ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of JNJ. Analyze the recent business situations of Johnson&Johnson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average JNJ stock price target is 185.44 with a high estimate of 201.00 and a low estimate of 153.00.

EPS

Institutional Holdings

Institutions: 3.89K

Institutional Holdings: 1.91B

% Owned: 72.61%

Shares Outstanding: 2.63B

TypeInstitutionsShares

Increased

1.42K

43.00M

New

339

13.70M

Decreased

1.14K

55.40M

Sold Out

2.48M

Performance
Asset Allocation
Dividend History

No Data

Industry

Pharmaceuticals

+0.98%

Pharmaceuticals & Medical Research

+0.89%

Key Executives

Chairman/Chief Executive Officer/Director

Alex Gorsky

Vice Chairman - Management/Chief Scientific Officer

Paulus Stoffels

Vice Chairman - Management

Joaquin Duato

Chief Financial Officer/Executive Vice President

Joseph Wolk

Chief Human Resource Officer/Executive Vice President

Peter Fasolo

Executive Vice President/General Counsel

Michael Ullmann

Executive Vice President

Ashley McEvoy

Executive Vice President

Ashley Mcevoy

Executive Vice President

Thibaut Mongon

Executive Vice President

Michael Sneed

Executive Vice President

Jennifer Taubert

Executive Vice President

Kathryn Wengel

Lead Director/Independent Director

Anne Mulcahy

Independent Director

Mary Beckerle

Independent Director

D. Scott Davis

Independent Director

Ian Davis

Independent Director

Jennifer Doudna

Independent Director

Marillyn Hewson

Independent Director

Hubert Joly

Independent Director

Mark McClellan

Independent Director

Mark Mcclellan

Independent Director

Charles Prince

Independent Director

A. Eugene Washington

Independent Director

Mark Weinberger

Independent Director

Nadja West

Independent Director

Ronald Williams

Declaration Date Dividend Per Share Ex-Div Date: 01/04/2021
Dividend USD 1.01
02/22/2021; 10/22/2020
Dividend USD 1.01
11/23/2020; 07/20/2020
Dividend USD 1.01
08/24/2020; 04/14/2020
Dividend USD 1.01
05/22/2020; 01/02/2020
Dividend USD 0.95
02/24/2020; 10/17/2019
Dividend USD 0.95
11/25/2019; 07/15/2019
Dividend USD 0.95
08/26/2019; 04/25/2019
Dividend USD 0.95
05/24/2019; 01/02/2019
Dividend USD 0.9
02/25/2019; 10/18/2018
Dividend USD 0.9
11/26/2018; 07/16/2018
Dividend USD 0.9
08/27/2018; 04/26/2018
Dividend USD 0.9
05/25/2018; 01/02/2018
Dividend USD 0.84
02/26/2018; 10/19/2017
Dividend USD 0.84
11/27/2017; 07/17/2017
Dividend USD 0.84
08/25/2017; 04/27/2017
Dividend USD 0.84
05/25/2017; 01/03/2017
Dividend USD 0.8
02/24/2017; 10/21/2016
Dividend USD 0.8
11/18/2016; 07/18/2016
Dividend USD 0.8
08/19/2016; 04/28/2016
Dividend USD 0.8
05/20/2016; 01/04/2016
Dividend USD 0.75
02/19/2016; 10/22/2015
Dividend USD 0.75
11/20/2015; 07/20/2015
Dividend USD 0.75
08/21/2015; 04/23/2015
Dividend USD 0.75
05/21/2015; 01/05/2015
Dividend USD 0.7
02/20/2015; 10/16/2014
Dividend USD 0.7
11/21/2014; 07/21/2014
Dividend USD 0.7
08/22/2014; 04/24/2014
Dividend USD 0.7
05/22/2014; 01/02/2014
Dividend USD 0.66
02/21/2014; 10/17/2013
Dividend USD 0.66
11/22/2013; 07/15/2013
Dividend USD 0.66
08/23/2013

All
Financials
Insiders

About JNJ

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Webull offers kinds of Johnson & Johnson stock information, including NYSE:JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.